HIV Citation List: October 25 - November 7, 2013

PubMed citations

1. S100A9 Protein Is a Novel Ligand for the CD85j Receptor and Its Interaction Is Implicated in the Control of HIV-1 Replication by NK Cells.Arnold, V., J.S. Cummings, U.Y. Moreno-Nieves, C. Didier, A. Gilbert, F. Barre-Sinoussi, and D. Scott-Algara. Retrovirology, 2013. 10(1): p. 122. PMID[24156302].

[PubMed]. HIV_1025-110713.

2. Design, Synthesis and Biological Evaluation of N2,N4-Disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine Derivatives as HIV-1 NNRTIs.Chen, W., P. Zhan, E. De Clercq, C. Pannecouque, J. Balzarini, X. Jiang, and X. Liu. Bioorganic & Medicinal Chemistry, 2013. 21(22): p. 7091-7100. PMID[24119448].

[PubMed]. HIV_1025-110713.

3. 6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as Dual Inhibitors of Recombinant HIV-1 Integrase and Ribonuclease H, Synthesized by a Parallel Synthesis Approach. Costi, R., M. Metifiot, F. Esposito, G. Cuzzucoli Crucitti, L. Pescatori, A. Messore, L. Scipione, S. Tortorella, L. Zinzula, E. Novellino, Y. Pommier, E. Tramontano, C. Marchand, and R. Di Santo. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24124919].

[PubMed]. HIV_1025-110713.

4. Biological Activity of Sporolide A and B from Salinispora tropica: in Silico Target Prediction Using Ligand Based Pharmacophore Mapping and in Vitro Activity Validation on HIV-1 Reverse Transcriptase.Dineshkumar, K., V. Aparna, K.Z. Madhuri, and W. Hopper. Chemical Biology & Drug Design, 2013. [Epub ahead of print]. PMID[24165098].

[PubMed]. HIV_1025-110713.

5. CXCR4-derived Synthetic Peptides Inducing anti-HIV-1 Antibodies.Hashimoto, C., W. Nomura, T. Narumi, M. Fujino, T. Nakahara, N. Yamamoto, T. Murakami, and H. Tamamura. Bioorganic & Medicinal Chemistry, 2013. 21(22): p. 6878-6885. PMID[24119449].

[PubMed]. HIV_1025-110713.

6. Small Molecule Fusion Inhibitors: Design, Synthesis and Biological Evaluation of (Z)-3-(5-(3-Benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and Related Derivatives Targeting HIV-1 gp41. He, X.Y., L. Lu, J. Qiu, P. Zou, F. Yu, X.K. Jiang, L. Li, S. Jiang, S. Liu, and L. Xie. Bioorganic & Medicinal Chemistry, 2013. 21(23): p. 7539-7548. PMID[23673219].

[PubMed]. HIV_1025-110713.

7. Terpenoids and Their anti-HIV-1 Activities from Excoecaria acerifolia.Huang, S.Z., X. Zhang, Q.Y. Ma, Y.T. Zheng, F.Q. Xu, H. Peng, H.F. Dai, J. Zhou, and Y.X. Zhao. Fitoterapia, 2013. 91: p. 224-230. PMID[24060906].

[PubMed]. HIV_1025-110713.

8. Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors. Joshi, A., J.B. Veron, J. Unge, A. Rosenquist, H. Wallberg, B. Samuelsson, A. Hallberg, and M. Larhed. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24160253].

[PubMed]. HIV_1025-110713.

9. 3-Hydroxyphthalic anhydride-modified Human Serum Albumin as a Microbicide Candidate against HIV Type 1 Entry by Targeting Both Viral Envelope Glycoprotein gp120 and Cellular Receptor CD4. Li, M., J. Duan, J. Qiu, F. Yu, X. Che, S. Jiang, and L. Li. AIDS Research and Human Retroviruses, 2013. 29(11): p. 1455-1464. PMID[23711095].

[PubMed]. HIV_1025-110713.

10. Arylazolylthioacetanilide. Part 11: Design, Synthesis and Biological Evaluation of 1,2,4-Triazole thioacetanilide Derivatives as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Li, Z., Y. Cao, P. Zhan, C. Pannecouque, J. Balzarini, E.D. Clercq, Y. Shen, and X. Liu. Medicinal Chemistry, 2013. 9(7): p. 968-973. PMID[23072552].

[PubMed]. HIV_1025-110713.

11. A Sorghum Xylanase Inhibitor-like Protein with Highly Potent Antifungal, Antitumor and HIV-1 Reverse Transcriptase Inhibitory Activities. Lin, P., J.H. Wong, T.B. Ng, V.S. Ho, and L. Xia. Food Chemistry, 2013. 141(3): p. 2916-2922. PMID[23871041].

[PubMed]. HIV_1025-110713.

12. 90K, an Interferon-stimulated Gene Product, Reduces the Infectivity of HIV-1.Lodermeyer, V., K. Suhr, N. Schrott, C. Kolbe, C.M. Sturzel, D. Krnavek, J. Munch, C. Dietz, T. Waldmann, F. Kirchhoff, and C. Goffinet. Retrovirology, 2013. 10(1): p. 111. PMID[24156545].

[PubMed]. HIV_1025-110713.

13. Proteasome Inhibitors Act as Bifunctional Antagonists of Human Immunodeficiency Virus Type 1 Latency and Replication. Miller, L.K., Y. Kobayashi, C.C. Chen, T.A. Russnak, Y. Ron, and J.P. Dougherty. Retrovirology, 2013. 10(1): p. 120. PMID[24156270].

[PubMed]. HIV_1025-110713.

14. Corrigendum: Externally Controlled on-demand Release of anti-HIV Drug Using Magneto-electric Nanoparticles as Carriers. Nair, M., R. Guduru, P. Liang, J. Hong, V. Sagar, and S. Khizroev. Nature Communications, 2013. 4: p. 2729. PMID[24157474].

[PubMed]. HIV_1025-110713.

15. 5,6-Dihydro-5-aza-2'-deoxycytidine Potentiates the anti-HIV-1 Activity of Ribonucleotide Reductase Inhibitors. Rawson, J.M., R.H. Heineman, L.B. Beach, J.L. Martin, E.K. Schnettler, M.J. Dapp, S.E. Patterson, and L.M. Mansky. Bioorganic & Medicinal Chemistry, 2013. 21(22): p. 7222-7228. PMID[24120088].

[PubMed]. HIV_1025-110713.

16. Synthesis, Docking, and Biological Studies of Phenanthrene beta-diketo acids as Novel HIV-1 Integrase Inhibitors. Sharma, H., T.W. Sanchez, N. Neamati, M. Detorio, R.F. Schinazi, X. Cheng, and J.K. Buolamwini. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6146-6151. PMID[24091080].

[PubMed]. HIV_1025-110713.

17. Clicking 3'-Azidothymidine into Novel Potent Inhibitors of Human Immunodeficiency Virus. Sirivolu, V.R., S.K. Vernekar, T. Ilina, N.S. Myshakina, M.A. Parniak, and Z. Wang. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24102161].

[PubMed]. HIV_1025-110713.

18. Minimalist Hybrid Ligand/Receptor-based Pharmacophore Model for CXCR4 Applied to a Small-library of Marine Natural Products Led to the Identification of Phidianidine a as a New CXCR4 Ligand Exhibiting Antagonist Activity.Vitale, R.M., M. Gatti, M. Carbone, F. Barbieri, V. Felicita, M. Gavagnin, T. Florio, and P. Amodeo. ACS Chemical Biology, 2013. [Epub ahead of print]. PMID[24102412].

[PubMed]. HIV_1025-110713.

19. Characterization of Novel Inhibitors of HIV-1 Replication That Function via Alteration of Viral RNA Processing and Rev Function. Wong, R.W., A. Balachandran, M. Haaland, P. Stoilov, and A. Cochrane. Nucleic Acids Research, 2013. 41(20): p. 9471-9483. PMID[23945945].

[PubMed]. HIV_1025-110713.

20. New Insights into Inhibition of Human Immunodeficiency Virus Type 1 Replication through Mutant tRNALys3. Wu, C., V.R. Nerurkar, and Y. Lu. Retrovirology, 2013. 10(1): p. 112. PMID[24156557].

[PubMed]. HIV_1025-110713.

21. Towards New C6-rigid S-DABO HIV-1 Reverse Transcriptase Inhibitors: Synthesis, Biological Investigation and Molecular Modeling Studies.Wu, H.Q., Z.H. Yan, W.X. Chen, Q.Q. He, F.E. Chen, E. De Clercq, J. Balzarini, D. Daelemans, and C. Pannecouque. Bioorganic & Medicinal Chemistry, 2013. 21(21): p. 6477-6483. PMID[24055077].

[PubMed]. HIV_1025-110713.

22. Modular Assembly of Dimeric HIV Fusion Inhibitor Peptides with Enhanced Antiviral Potency. Xiao, J. and T.J. Tolbert. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6046-6051. PMID[24094817].

[PubMed]. HIV_1025-110713.

23. Design and Synthesis of Novel Pyrimidone Analogues as HIV-1 Integrase Inhibitors.Yu, S., T.W. Sanchez, Y. Liu, Y. Yin, N. Neamati, and G. Zhao. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6134-6137. PMID[24084160].

[PubMed]. HIV_1025-110713.

ISI Web of Knowledge Citations

24. Lamivudine-pegylated Chitosan: A Novel Effective Nanosized Antiretroviral Agent. Aghasadeghi, M.R., H. Heidari, S.M. Sadat, S. Irani, S. Amini, S.D. Siadat, M.E. Fazlhashemy, R. Zabihollahi, S.M. Atyabi, S.B. Momen, M.S. Khosraavy, M. Davari, T. Darvishmohammadi, M. Doroudian, and M.S. Ardestani. Current HIV Research, 2013. 11(4): p. 309-320. ISI[000324868700008].

[WOS]. HIV_1025-110713.

25. Triflic acid Mediated Fries Rearrangement of 3-Dienyl-2-azetidinones: Facile Synthesis of 3-(But-2-enylidene)quinolin-4(3H)-ones. Anand, A., V. Mehra, and V. Kumar. Synlett, 2013. 24(7): p. 865-867. ISI[000317957100017].

[WOS]. HIV_1025-110713.

26. Identification of Novel Inhibitors of HIV-1 Integrase Using Pharmacophore-based Virtual Screening Combined with Molecular Docking Strategies. Ardakani, A. and J.B. Ghasemi. Medicinal Chemistry Research, 2013. 22(11): p. 5545-5556. ISI[000325076400042].

[WOS]. HIV_1025-110713.

27. Biological Properties of Water-soluble Phosphorhydrazone Dendrimers.Caminade, A.M., C.O. Turrin, and J.P. Majoral. Brazilian Journal of Pharmaceutical Sciences, 2013. 49: p. 33-44. ISI[000324915100004].

[WOS]. HIV_1025-110713.

28. Inhibition of HIV-1 Reverse Transcriptase-catalyzed Synthesis by Intercalated DNA Benzo[a]pyrene 7,8-dihydrodiol-9,10-epoxide Adducts. Chary, P., W.A. Beard, S.H. Wilson, and S. Lloyd. PloS One, 2013. 8(9): p. e72131. ISI[000324777300004].

[WOS]. HIV_1025-110713.

29. Chimeric Cyanovirin-MPER Recombinantly Engineered Proteins Cause Cell-free Virolysis of HIV-1. Contarino, M., A.R. Bastian, R.V.K. Sundaram, K. McFadden, C. Duffy, V. Gangupomu, M. Baker, C. Abrams, and I. Chaiken. Antimicrobial Agents and Chemotherapy, 2013. 57(10): p. 4743-4750. ISI[000324480300019].

[WOS]. HIV_1025-110713.

30. A Three Step Continuous Flow Synthesis of the Biaryl Unit of the HIV Protease Inhibitor Atazanavir. Dalla-Vechia, L., B. Reichart, T. Glasnov, L.S.M. Miranda, C.O. Kappe, and R. de Souza. Organic & Biomolecular Chemistry, 2013. 11(39): p. 6806-6813. ISI[000325119600019].

[WOS]. HIV_1025-110713.

31. Production of Oleanolic acid glycosides by Hairy Root Established Cultures of Calendula officinalis L. Dlugosz, M., E. Wiktorowska, A. Wisniewska, and C. Paczkowski. Acta Biochimica Polonica, 2013. 60(3): p. 467-473. ISI[000325237000027].

[WOS]. HIV_1025-110713.

32. Synthesis of New Imidazo[4,5-e][1,3]thiazolo-[3,2-b][1,2,4]triazine Derivatives.Gazieva, G.A., S.A. Serkov, N.V. Sigai, N.N. Kostikova, Y.V. Nelyubina, E.A. Shishkova, and A.N. Kravchenko. Chemistry of Heterocyclic Compounds, 2013. 49(7): p. 1097-1101. ISI[000325115200018].

[WOS]. HIV_1025-110713.

33. In Vitro and ex Vivo Evaluations on Transdermal Delivery of the HIV Inhibitor IQP-0410. Ham, A.S., W. Lustig, L. Yang, A. Boczar, K.W. Buckheit, and R.W. Buckheit. PloS One, 2013. 8(9): p. e75306. ISI[000324695900105].

[WOS]. HIV_1025-110713.

34. HIV-1 Suppression and Durable Control by Combining Single Broadly Neutralizing Antibodies and Antiretroviral Drugs in Humanized Mice.Horwitz, J.A., A. Halper-Stromberg, H. Mouquet, A.D. Gitlin, A. Tretiakova, T.R. Eisenreich, M. Malbec, S. Gravemann, E. Billerbeck, M. Dorner, H. Buning, O. Schwartz, E. Knops, R. Kaiser, M.S. Seaman, J.M. Wilson, C.M. Rice, A. Ploss, P.J. Bjorkman, F. Klein, and M.C. Nussenzweig. Proceedings of the National Academy of Sciences of the United States of America, 2013. 110(41): p. 16538-16543. ISI[000325395600061].

[WOS]. HIV_1025-110713.

35. Synthesis and NMR Elucidation of Pentacycloundecane-derived Hydroxy acid Peptides as Potential anti-HIV-1 Agents. Karpoormath, R., F. Albericio, T. Govender, G.E.M. Maguire, and H.G. Kruger. Structural Chemistry, 2013. 24(5): p. 1461-1471. ISI[000324797000009].

[WOS]. HIV_1025-110713.

36. Synthesis of Electron-rich Cyclotriazadisulfonamide (CADA) Analogs as anti-HIV and Human CD4 Receptor Down-modulating Agents.Khan, C., N.C. Pflug, D. Schols, K. Vermeire, and T.W. Bell. Abstracts of Papers of the American Chemical Society, 2013. 245. ISI[000324303602425].

[WOS]. HIV_1025-110713.

37. Identification of Two HIV Inhibitors That Also Inhibit Human RNaseH2.Kim, J., J. Yoon, M. Ju, Y. Lee, T.H. Kim, J. Kim, P. Sommer, Z. No, J. Cechetto, and S.J. Han. Molecules and Cells, 2013. 36(3): p. 212-218. ISI[000324643100004].

[WOS]. HIV_1025-110713.

38. Flavonoid Compounds from Arundina graminifolia.Li, Y.K., L.Y. Yang, L.D. Shu, Y.Q. Shen, Q.F. Hu, and Z.Y. Xia. Asian Journal of Chemistry, 2013. 25(9): p. 4922-4924. ISI[000325087800049].

[WOS]. HIV_1025-110713.

39. Anti-HIV-1 Activity and Structure-activity-relationship Study of a Fucosylated glycosaminoglycan from an Echinoderm by Targeting the Conserved CD4 Induced Epitope. Lian, W., M.Y. Wu, N. Huang, N. Gao, C. Xiao, Z. Li, Z.G. Zhang, Y.T. Zheng, W.L. Peng, and J.H. Zhao. Biochimica et Biophysica Acta-General Subjects, 2013. 1830(10): p. 4681-4691. ISI[000323854900031].

[WOS]. HIV_1025-110713.

40. Biotransformation of Oleanolic and Maslin acids by Rhizomucor miehei.Martinez, A., F. Rivas, A. Perojil, A. Parra, A. Garcia-Granados, and A. Fernandez-Vivas. Phytochemistry, 2013. 94: p. 229-237. ISI[000324721100026].

[WOS]. HIV_1025-110713.

41. Synthesis and Evaluation of Coumarin Derivatives as Potential Dual-action HIV-1 Protease and Reverse Transcriptase Inhibitors.Olomola, T.O., R. Klein, N. Mautsa, Y. Sayed, and P.T. Kaye. Bioorganic & Medicinal Chemistry, 2013. 21(21): p. 6856-6856. ISI[000325164500064].

[WOS]. HIV_1025-110713.

42. Pharmacokinetic Interactions between 20(S)-Ginsenoside Rh2 and the HIV Protease Inhibitor Ritonavir in Vitro and in Vivo.Shi, J., B. Cao, W.B. Zha, X.L. Wu, L.S. Liu, W.J. Xiao, R.R. Gu, R.B. Sun, X.Y. Yu, T. Zheng, M.J. Li, X.W. Wang, J. Zhou, Y. Mao, C. Ge, T. Ma, W.J. Xia, J.Y. Aa, G.J. Wang, and C.X. Liu. Acta Pharmacologica Sinica, 2013. 34(10): p. 1349-1358. ISI[000325276400011].

[WOS]. HIV_1025-110713.

43. An Efficient Synthesis of Dichotomine A via Cyclization of L-Tryptophan Derivative. Shi, X.X., D. He, S.B. Li, X. Lei, and H. Yang. Asian Journal of Chemistry, 2013. 25(11): p. 6387-6390. ISI[000325089600117].

[WOS]. HIV_1025-110713.

44. Towards the Synthesis of Novel 1,3-Azaborines as Potential HIV-1 Protease Inhibitors. Sigurjonsson, K., M.D. Frank, J.D. Schreiber, J.J. Jennings, A.L. Faulkner, and L. Fabry-Asztalos. Abstracts of Papers of the American Chemical Society, 2013. 245. ISI[000324303602426].

[WOS]. HIV_1025-110713.

45. Phenyl Hydrazone Bearing Pyrazole and Pyrimidine Scaffolds: Design and Discovery of a Novel Class of Non-Nucleoside Reverse Transcriptase Inhibitors (NNTRIs) against HIV-1 and Their Antibacterial Properties.Singh, U.P., H.R. Bhat, A. Verma, M.K. Kumawat, R. Kaur, S.K. Gupta, and R.K. Singh. RSC Advances, 2013. 3(38): p. 17335-17348. ISI[000325272100060].

[WOS]. HIV_1025-110713.

46. Design, Synthesis and Biological Evaluation of TAR and cTAR Binders as HIV-1 Nucleocapsid Inhibitors. Sosic, A., F. Frecentese, E. Perissutti, L. Sinigaglia, V. Santagada, G. Caliendo, E. Magli, A. Ciano, G. Zagotto, C. Parolin, and B. Gatto. MedChemComm, 2013. 4(10): p. 1388-1393. ISI[000324928100009].

[WOS]. HIV_1025-110713.

47. Discovery of Novel HIV Integrase Inhibitors Part 1: Molecular Design and SAR of Azabicyclic carbamoyl pyridone Inhibitors.Taoda, Y., B.A. Johns, T. Akiyama, H. Yoshida, T. Taishi, T. Kawasuji, H. Murai, T. Yoshinaga, A. Sato, and T. Fujiwara. Abstracts of Papers of the American Chemical Society, 2013. 245. ISI[000324303602421].

[WOS]. HIV_1025-110713.

48. Is the Conformational Flexibility of Piperazine Derivatives Important to Inhibit HIV-1 Replication? Teixeira, C., N. Serradji, S. Amroune, K. Storck, C. Rogez-Kreuz, P. Clayette, F. Barbault, and F. Maurel. Journal of Molecular Graphics & Modelling, 2013. 44: p. 91-103. ISI[000324965300010].

[WOS]. HIV_1025-110713.

49. Design, Synthesis, and Biological Evaluation of Novel 3,5-Disubstituted-1,2,6-thiadiazine-1,1-dione Derivatives as HIV-1 NNRTIs.Tian, Y., D. Rai, P. Zhan, C. Pannecouque, J. Balzarini, E. De Clercq, H.Q. Liu, and X.Y. Liu. Chemical Biology & Drug Design, 2013. 82(4): p. 384-393. ISI[000324921500004].

[WOS]. HIV_1025-110713.

50. Synthesis and Biological Evaluation of Acyclic Phosphonic acid Nucleoside Derivatives. Wainwright, P., A. Maddaford, X.R. Zhang, H. Billington, D. Leese, R. Glen, D.C. Pryde, D.S. Middleton, P.T. Stephenson, and S. Sutton. Nucleosides Nucleotides & Nucleic Acids, 2013. 32(9): p. 477-492. ISI[000324977900001].

[WOS]. HIV_1025-110713.

51. The Antiviral Lectin Cyanovirin-N: Probing Multivalency and Glycan Recognition through Experimental and Computational Approaches.Woodrum, B.W., J.D. Maxwell, A. Bolia, S.B. Ozkan, and G. Ghirlanda. Biochemical Society Transactions, 2013. 41: p. 1170-1176. ISI[000324910200009].

[WOS]. HIV_1025-110713.

52. A New 4-Hydroxyisoflavanone from the Root of Oriental Tobacco and Their Antivirus Activities. Wu, X.X., Y. Xu, H.Q. Leng, G.Y. Yang, Y.K. Chen, Q.F. Hu, and M.M. Miao. Asian Journal of Chemistry, 2013. 25(11): p. 6133-6135. ISI[000325089600059].

[WOS]. HIV_1025-110713.

53. DNA Duplexes with Hydrophobic Modifications Inhibit Fusion between HIV-1 and Cell Membranes. Xu, L., L.F. Cai, X.L. Chen, X.F. Jiang, H.H. Chong, B.H. Zheng, K. Wang, J.L. He, W. Chen, T. Zhang, M.S. Cheng, Y.X. He, and K.L. Liu. Antimicrobial Agents and Chemotherapy, 2013. 57(10): p. 4963-4970. ISI[000324480300045].

[WOS]. HIV_1025-110713.

Patent Citations

54. Triazines with Suitable Spacers for Treatment and/or Prevention of HIV Infections and Their Preparation. Heeres, J., P. Van Der Veken, J. Joossens, V. Muthusamy, K. Augustyns, K.K.F. Arieen, G.L.E. Vanham, and P. Lewi. Patent. 2013. 2013-EP55525 2013139727: 40pp.

[Patent]. HIV_1025-110713.

55. Tannin Inhibitors of HIV. Kraus, G.A. and W. Maury. Patent. 2013. 2013-13788691 20130252909: 28pp.

[Patent]. HIV_1025-110713.

56. Preparation of 3,28-Disubstituted betulinic acid Derivatives as anti-HIV Agents. Lee, K.-H., K. Qian, D. Yu, I.D. Bori, C.-H. Chen, and L. Huang. Patent. 2013. 2013-US28668 2013148067: 46pp.

[Patent]. HIV_1025-110713.

57. Lipopeptide Conjugates Comprising Sphingolipid and HIV gp41 Derived Peptides for Treatment of Retrovirus Infections. Shai, Y. and A. Ashkenazi. Patent. 2013. 2013-IL50305 2013150532: 50pp.

[Patent]. HIV_1025-110713.

58. HIV Replication Inhibitor. Sugiyama, S., T. Akiyama, and Y. Taoda. Patent. 2013. 2013-JP61575 2013157622: 181pp.

[Patent]. HIV_1025-110713.

59. Cyclic Hydrazine Derivatives as HIV Attachment Inhibitors. Wang, T., J.F. Kadow, N.A. Meanwell, and L.G. Hamann. Patent. 2013. 2013-US30772 2013138436: 93pp.

[Patent]. HIV_1025-110713.

60. 6-Cyclohexylmethyl-2-aromatic Ring Carbonyl-substituted N-Dabo-Like Compounds, Their Synthetic Method and Application as anti-HIV Agents. Zhang, S., X. Wang, X. Fang, Y. Li, X. Li, and M. Xu. Patent. 2013. 2013-10235303 103288747: 14pp.

[Patent]. HIV_1025-110713.